What is the current annual SG&A of GSK?

As of today, GSK annual SG&A is $1.24B

What is 1-year change in GSK annual SG&A?

GSK annual SG&A is up +389.64% year-over-year

What is 3-year change in GSK annual SG&A?

GSK annual SG&A is up +423.81% over the past 3 years

How far is GSK annual SG&A from its all-time high?

GSK annual SG&A is currently -93.85% below its historical high of $20.15B set on December 31, 2010

How does GSK annual SG&A rank versus sector peers?

GSK annual SG&A is higher than 99.03% of companies in Healthcare sector

When is GSK next annual earnings release?

The next annual earnings release for GSK is on February 3, 2027

What is the current quarterly SG&A of GSK?

As of today, GSK quarterly SG&A is $3.20B

What is GSK quarterly SG&A most recent change?

GSK quarterly SG&A was up +8.36% on September 30, 2026

What is 1-year change in GSK quarterly SG&A?

GSK quarterly SG&A is up +6.06% year-over-year

How far is GSK quarterly SG&A from its all-time high?

GSK quarterly SG&A is currently -54.39% below its historical high of $7.02B set on December 31, 2010

How does GSK quarterly SG&A rank versus sector peers?

GSK quarterly SG&A is higher than 99.53% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

What is the current TTM SG&A of GSK?

As of today, GSK TTM SG&A is $60.78B

What is GSK TTM SG&A most recent change?

GSK TTM SG&A was up +5.31% on September 30, 2026

What is 1-year change in GSK TTM SG&A?

GSK TTM SG&A is up +410.86% year-over-year

How far is GSK TTM SG&A from its all-time high?

GSK TTM SG&A is currently at its all-time high

How does GSK TTM SG&A rank versus sector peers?

GSK TTM SG&A is higher than 98.02% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 3, 2027

GSK Plc (GSK) SG&A History & Chart Since 1986

Annual SG&A

$1.24B$985.81M+389.64%

December 31, 2025

Summary

Current Value: As of today, GSK annual SG&A is $1.24B, up +389.64% on December 31, 2025
Historical Performance: GSK annual SG&A is up +423.81% over the past 3 years, up +136.78% over the past 5 years
All-Time High Comparison: GSK annual SG&A is currently -93.85% below its historical high of $20.15B set on December 31, 2010
3-Year Low Comparison: GSK annual SG&A is +423.81% above its 3-year low of $236.50M reached on an earlier date
Sector Comparison: GSK annual SG&A is higher than 99.03% of companies in Healthcare sector

SG&A Chart

beforeafter

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual SG&A	Dec 31, 25	$1.24B	+389.6%	+423.8%	+136.8%	-93.8%
Quarterly SG&A	Sep 30, 26	$3.20B	+6.1%	+10.2%	+38.4%	-1.1%
TTM SG&A	Sep 30, 26	$60.78B	+410.9%	+442.3%	+398.3%	+246.5%
Price	Nov 6, 26	$50.33	+6.9%	+44.7%	+13.5%	+11.1%
Annual Operating Expenses	Dec 31, 25	$21.78B	+5.0%	+38.4%	+13.7%	-10.1%
Annual Operating Profit	Dec 31, 25	$9.45B	+30.6%	+14.8%	-10.0%	+22.9%
Annual D&A	Dec 31, 25	$3.05B	-6.5%	+15.3%	+1.1%	+17.7%
Annual Revenue	Dec 31, 25	$43.05B	+7.4%	+19.2%	-1.5%	-1.8%

SG&A Highs

GSK Annual SG&A Highs Comparison
Period	High	Date	Current
3Y	$1.24B	Dec 31, 25	at high
5Y	$1.24B	Dec 31, 25	at high
All	$20.15B	Dec 31, 10	-93.8%

SG&A Lows

GSK Annual SG&A Lows Comparison
Period	Low	Date	Current
3Y	$236.50M	N/A	+423.8%
5Y	$232.43M	Dec 31, 21	+433.0%
All	$0.00	Jun 30, 91	N/A

SG&A History

Year	Value	Change
2025	$1.24B	+389.6%
2024	$253.01M	+2.3%
2023	$247.37M	+4.6%
2022	$236.50M	+1.8%
2021	$232.43M	-55.6%
2020	$523.20M	+4.4%
2019	$501.37M	-96.2%
2018	$13.22B	+6.1%
2017	$12.46B	-1.2%
2016	$12.60B	-10.6%
2015	$14.10B	+3.9%
2014	$13.58B	+10.5%
2013	$12.29B	-11.5%
2012	$13.88B	+4.3%
2011	$13.32B	-33.9%
2010	$20.15B	+33.8%
2009	$15.05B	+6.8%
2008	$14.09B	+1.3%
2007	$13.92B	+4.2%
2006	$13.36B	+1.4%

Year	Value	Change
2005	$13.17B	-0.1%
2004	$13.19B	+6.5%
2003	$12.38B	>+9,900.0%
2002	$0.00	0.0%
2001	$0.00	0.0%
2000	$0.00	0.0%
1999	$0.00	-100.0%
1998	$4.45B	+3.2%
1997	$4.32B	+5.0%
1996	$4.11B	-1.8%
1995	$4.19B	+40.7%
1994	$2.98B	>+9,900.0%
1993	$0.00	0.0%
1992	$0.00	0.0%
1991	$0.00	-100.0%
1990	$63.47M	+42.2%
1989	$44.62M	+154.5%
1988	$17.54M	+91.6%
1987	$9.15M	+27.1%
1986	$7.20M	-

FAQ

What is the current annual SG&A of GSK?: As of today, GSK annual SG&A is $1.24B
What is 1-year change in GSK annual SG&A?: GSK annual SG&A is up +389.64% year-over-year
What is 3-year change in GSK annual SG&A?: GSK annual SG&A is up +423.81% over the past 3 years
How far is GSK annual SG&A from its all-time high?: GSK annual SG&A is currently -93.85% below its historical high of $20.15B set on December 31, 2010
How does GSK annual SG&A rank versus sector peers?: GSK annual SG&A is higher than 99.03% of companies in Healthcare sector
When is GSK next annual earnings release?: The next annual earnings release for GSK is on February 3, 2027

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Quarterly SG&A

$3.20B$247.11M+8.36%

September 30, 2026

Summary

Current Value: As of today, GSK quarterly SG&A is $3.20B, up +8.36% on September 30, 2026
Historical Performance: GSK quarterly SG&A is up +6.06% year-over-year, up +10.23% over the past 3 years
All-Time High Comparison: GSK quarterly SG&A is currently -54.39% below its historical high of $7.02B set on December 31, 2010
3-Year Low Comparison: GSK quarterly SG&A is +22.86% above its 3-year low of $2.61B reached on March 31, 2025
Sector Comparison: GSK quarterly SG&A is higher than 99.53% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly SG&A	Sep 30, 26	$3.20B	+8.4%	+6.1%	+10.2%	+38.4%
Annual SG&A	Dec 31, 25	$1.24B	–	+389.6%	+423.8%	+136.8%
TTM SG&A	Sep 30, 26	$60.78B	+392.6%	+410.9%	+442.3%	+398.3%
Price	Nov 6, 26	$50.33	-3.5%	+6.9%	+44.7%	+13.5%
Quarterly Operating Expenses	Sep 30, 26	$5.44B	+3.6%	+8.0%	+18.1%	+29.7%
Quarterly Operating Profit	Sep 30, 26	$3.45B	+7.3%	-0.4%	+21.6%	+55.4%
Quarterly D&A	Sep 30, 26	$998.44M	+236.1%	-4.8%	+34.1%	-20.9%
Quarterly Revenue	Sep 30, 26	$11.94B	+5.8%	+3.6%	+15.8%	+30.8%

Quarterly SG&A Highs

GSK Quarterly SG&A Highs Comparison
Period	High	Date	Current
1Y	$3.51B	Dec 31, 25	-8.7%
3Y	$4.94B	Sep 30, 24	-35.2%
5Y	$4.94B	Sep 30, 24	-35.2%
All	$7.02B	Dec 31, 10	-54.4%

Quarterly SG&A Lows

GSK Quarterly SG&A Lows Comparison
Period	Low	Date	Current
1Y	$2.86B	Mar 31, 26	+12.2%
3Y	$2.61B	Mar 31, 25	+22.9%
5Y	$2.31B	N/A	+38.4%
All	$0.00	Mar 31, 01	N/A

Quarterly SG&A History

Month	Value	Change
Sep 2026	$3.20B	+8.4%
Jun 2026	$2.96B	+3.5%
Mar 2026	$2.86B	-18.6%
Dec 2025	$3.51B	+16.2%
Sep 2025	$3.02B	+5.6%
Jun 2025	$2.86B	+9.7%
Mar 2025	$2.61B	-23.6%
Dec 2024	$3.41B	-30.9%
Sep 2024	$4.94B	+58.8%
Jun 2024	$3.11B	+17.5%
Mar 2024	$2.65B	-20.4%
Dec 2023	$3.32B	+14.3%
Sep 2023	$2.91B	+2.3%
Jun 2023	$2.84B	+9.0%
Mar 2023	$2.60B	-8.9%
Dec 2022	$2.86B	+18.3%
Sep 2022	$2.42B	-6.7%
Jun 2022	$2.59B	-32.1%
Mar 2022	$3.81B	+29.0%
Dec 2021	$2.96B	+27.8%
Sep 2021	$2.31B	-2.1%
Jun 2021	$2.36B	-29.4%
Mar 2021	$3.35B	-19.8%
Dec 2020	$4.18B	+21.1%
Sep 2020	$3.45B	+2.5%
Jun 2020	$3.36B	-9.7%
Mar 2020	$3.73B	-15.9%
Dec 2019	$4.43B	+24.3%
Sep 2019	$3.56B	+7.1%
Jun 2019	$3.33B	+3.2%
Mar 2019	$3.23B	-4.3%
Dec 2018	$3.37B	+2.3%
Sep 2018	$3.29B	-1.4%
Jun 2018	$3.34B	+3.9%
Mar 2018	$3.22B	-4.3%
Dec 2017	$3.36B	+11.3%
Sep 2017	$3.02B	-0.9%
Jun 2017	$3.05B	+0.2%
Mar 2017	$3.04B	-9.3%
Dec 2016	$3.35B	+11.4%
Sep 2016	$3.01B	-2.5%
Jun 2016	$3.09B	-0.5%
Mar 2016	$3.10B	-18.2%
Dec 2015	$3.79B	+25.2%
Sep 2015	$3.03B	-22.9%
Jun 2015	$3.93B	+16.8%
Mar 2015	$3.36B	-3.8%
Dec 2014	$3.49B	+4.8%
Sep 2014	$3.33B	-4.1%
Jun 2014	$3.48B	+6.1%
Mar 2014	$3.28B	+28.2%
Dec 2013	$2.55B	-16.9%
Sep 2013	$3.07B	-9.6%
Jun 2013	$3.40B	+5.5%

Month	Value	Change
Mar 2013	$3.23B	-8.4%
Dec 2012	$3.52B	-0.2%
Sep 2012	$3.53B	+1.5%
Jun 2012	$3.48B	+3.4%
Mar 2012	$3.37B	+22.1%
Dec 2011	$2.76B	-14.9%
Sep 2011	$3.24B	-15.3%
Jun 2011	$3.82B	+10.6%
Mar 2011	$3.46B	-50.8%
Dec 2010	$7.02B	+120.7%
Sep 2010	$3.18B	-49.3%
Jun 2010	$6.27B	+72.6%
Mar 2010	$3.64B	-24.7%
Dec 2009	$4.83B	+37.2%
Sep 2009	$3.52B	+1.9%
Jun 2009	$3.45B	+9.5%
Mar 2009	$3.15B	-10.2%
Dec 2008	$3.51B	+3.6%
Sep 2008	$3.39B	-4.8%
Jun 2008	$3.56B	+2.6%
Mar 2008	$3.47B	+0.7%
Dec 2007	$3.45B	+5.5%
Sep 2007	$3.27B	-10.6%
Jun 2007	$3.66B	+11.9%
Mar 2007	$3.27B	>+9,900.0%
Dec 2006	$0.00	0.0%
Sep 2006	$0.00	0.0%
Jun 2006	$0.00	0.0%
Mar 2006	$0.00	0.0%
Dec 2005	$0.00	0.0%
Sep 2005	$0.00	0.0%
Jun 2005	$0.00	0.0%
Mar 2005	$0.00	0.0%
Dec 2004	$0.00	0.0%
Sep 2004	$0.00	0.0%
Jun 2004	$0.00	0.0%
Mar 2004	$0.00	0.0%
Dec 2003	$0.00	0.0%
Sep 2003	$0.00	0.0%
Jun 2003	$0.00	0.0%
Mar 2003	$0.00	0.0%
Dec 2002	$0.00	0.0%
Sep 2002	$0.00	0.0%
Jun 2002	$0.00	0.0%
Mar 2002	$0.00	0.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	0.0%
Jun 2001	$0.00	0.0%
Mar 2001	$0.00	-100.0%
Sep 2000	$2.56B	-7.7%
Jun 2000	$2.77B	+10.6%
Mar 2000	$2.50B	+117.0%
Jun 1999	$1.15B	+5.2%
Jun 1998	$1.10B	-

FAQ

What is the current quarterly SG&A of GSK?: As of today, GSK quarterly SG&A is $3.20B
What is GSK quarterly SG&A most recent change?: GSK quarterly SG&A was up +8.36% on September 30, 2026
What is 1-year change in GSK quarterly SG&A?: GSK quarterly SG&A is up +6.06% year-over-year
How far is GSK quarterly SG&A from its all-time high?: GSK quarterly SG&A is currently -54.39% below its historical high of $7.02B set on December 31, 2010
How does GSK quarterly SG&A rank versus sector peers?: GSK quarterly SG&A is higher than 99.53% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

TTM SG&A

$60.78B$3.07B+5.31%

September 30, 2026

Summary

Current Value: As of today, GSK TTM SG&A is $60.78B, up +5.31% on September 30, 2026
Historical Performance: GSK TTM SG&A is up +410.86% year-over-year, up +442.29% over the past 3 years
All-Time High Comparison: GSK TTM SG&A is currently at its all-time high
3-Year Low Comparison: GSK TTM SG&A is +94.88% above its 3-year low of $31.19B reached on an earlier date
Sector Comparison: GSK TTM SG&A is higher than 98.02% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM SG&A	Sep 30, 26	$60.78B	+392.6%	+410.9%	+442.3%	+398.3%
Annual SG&A	Dec 31, 25	$1.24B	–	+389.6%	+423.8%	+136.8%
Quarterly SG&A	Sep 30, 26	$3.20B	+8.4%	+6.1%	+10.2%	+38.4%
Price	Nov 6, 26	$50.33	-3.5%	+6.9%	+44.7%	+13.5%
TTM Operating Profit	Sep 30, 26	$11.12B	-0.1%	+6.4%	+35.9%	+36.6%
TTM D&A	Sep 30, 26	$3.31B	-1.5%	-30.3%	+63.7%	-44.4%
TTM Revenue	Sep 30, 26	$44.97B	+0.9%	+6.9%	+23.6%	+15.1%

TTM SG&A Highs

GSK TTM SG&A Highs Comparison
Period	High	Date	Current
1Y	$60.78B	N/A	at high
3Y	$60.78B	N/A	at high
5Y	$60.78B	N/A	at high
All	$60.78B	N/A	at high

TTM SG&A Lows

GSK TTM SG&A Lows Comparison
Period	Low	Date	Current
1Y	$46.02B	N/A	+32.1%
3Y	$31.19B	N/A	+94.9%
5Y	$25.52B	N/A	+138.2%
All	-$29.95B	N/A	+302.9%

TTM SG&A History

Month	Value	Change
Sep 2026	$12.52B	+1.5%
Jun 2026	$12.34B	+0.8%
Mar 2026	$12.24B	+2.1%
Dec 2025	$11.99B	+0.8%
Sep 2025	$11.90B	-13.9%
Jun 2025	$13.82B	-1.8%
Mar 2025	$14.07B	-0.3%
Dec 2024	$14.11B	+0.6%
Sep 2024	$14.02B	+17.0%
Jun 2024	$11.98B	+2.3%
Mar 2024	$11.71B	+0.4%
Dec 2023	$11.67B	+4.1%
Sep 2023	$11.21B	+4.6%
Jun 2023	$10.72B	+2.4%
Mar 2023	$10.47B	-10.4%
Dec 2022	$11.68B	-0.8%
Sep 2022	$11.78B	+0.9%
Jun 2022	$11.67B	+2.0%
Mar 2022	$11.45B	+4.3%
Dec 2021	$10.98B	-10.0%
Sep 2021	$12.20B	-8.5%
Jun 2021	$13.33B	-7.0%
Mar 2021	$14.33B	-2.6%
Dec 2020	$14.71B	-1.7%
Sep 2020	$14.97B	-0.8%
Jun 2020	$15.08B	+0.2%
Mar 2020	$15.05B	+3.4%
Dec 2019	$14.55B	+7.9%
Sep 2019	$13.49B	+2.1%
Jun 2019	$13.22B	-0.1%
Mar 2019	$13.23B	+0.1%
Dec 2018	$13.22B	+0.1%
Sep 2018	$13.21B	+2.1%
Jun 2018	$12.94B	+2.3%
Mar 2018	$12.64B	+1.4%
Dec 2017	$12.46B	+0.1%
Sep 2017	$12.45B	+0.1%
Jun 2017	$12.44B	-0.3%
Mar 2017	$12.48B	-0.5%
Dec 2016	$12.54B	-3.4%
Sep 2016	$12.98B	-0.1%
Jun 2016	$13.00B	-6.1%
Mar 2016	$13.84B	-1.8%
Dec 2015	$14.10B	+2.1%
Sep 2015	$13.81B	-2.2%
Jun 2015	$14.12B	+3.3%
Mar 2015	$13.67B	+0.6%
Dec 2014	$13.58B	+7.4%
Sep 2014	$12.64B	+2.1%
Jun 2014	$12.38B	+0.6%
Mar 2014	$12.31B	+0.4%
Dec 2013	$12.26B	-7.3%
Sep 2013	$13.23B	-3.3%
Jun 2013	$13.68B	-0.6%

Month	Value	Change
Mar 2013	$13.76B	-1.0%
Dec 2012	$13.90B	+5.8%
Sep 2012	$13.13B	+2.3%
Jun 2012	$12.84B	-2.6%
Mar 2012	$13.18B	-0.7%
Dec 2011	$13.27B	-24.3%
Sep 2011	$17.54B	+0.3%
Jun 2011	$17.48B	-12.3%
Mar 2011	$19.93B	-0.9%
Dec 2010	$20.11B	+12.2%
Sep 2010	$17.92B	-1.9%
Jun 2010	$18.26B	+18.3%
Mar 2010	$15.44B	+3.2%
Dec 2009	$14.96B	+9.7%
Sep 2009	$13.64B	+1.0%
Jun 2009	$13.51B	-0.8%
Mar 2009	$13.61B	-2.3%
Dec 2008	$13.93B	+0.5%
Sep 2008	$13.86B	+0.9%
Jun 2008	$13.74B	-0.7%
Mar 2008	$13.84B	+1.5%
Dec 2007	$13.64B	+33.8%
Sep 2007	$10.19B	+47.2%
Jun 2007	$6.93B	+111.9%
Mar 2007	$3.27B	>+9,900.0%
Dec 2006	$0.00	0.0%
Sep 2006	$0.00	0.0%
Jun 2006	$0.00	0.0%
Mar 2006	$0.00	0.0%
Dec 2005	$0.00	0.0%
Sep 2005	$0.00	0.0%
Jun 2005	$0.00	0.0%
Mar 2005	$0.00	0.0%
Dec 2004	$0.00	0.0%
Sep 2004	$0.00	0.0%
Jun 2004	$0.00	0.0%
Mar 2004	$0.00	0.0%
Dec 2003	$0.00	0.0%
Sep 2003	$0.00	0.0%
Jun 2003	$0.00	0.0%
Mar 2003	$0.00	0.0%
Dec 2002	$0.00	0.0%
Sep 2002	$0.00	0.0%
Jun 2002	$0.00	0.0%
Mar 2002	$0.00	0.0%
Dec 2001	$0.00	0.0%
Sep 2001	$0.00	-100.0%
Jun 2001	$2.56B	-52.0%
Mar 2001	$5.33B	-32.0%
Sep 2000	$7.83B	+48.5%
Jun 2000	$5.27B	+44.1%
Mar 2000	$3.66B	+217.0%
Jun 1999	$1.15B	+5.2%
Jun 1998	$1.10B	-

FAQ

What is the current TTM SG&A of GSK?: As of today, GSK TTM SG&A is $60.78B
What is GSK TTM SG&A most recent change?: GSK TTM SG&A was up +5.31% on September 30, 2026
What is 1-year change in GSK TTM SG&A?: GSK TTM SG&A is up +410.86% year-over-year
How far is GSK TTM SG&A from its all-time high?: GSK TTM SG&A is currently at its all-time high
How does GSK TTM SG&A rank versus sector peers?: GSK TTM SG&A is higher than 98.02% of companies in Healthcare sector
When is GSK next earnings release?: The next earnings release for GSK is on February 3, 2027

SG&A Formula

SG&A = Operating Expenses − Cost Of Goods Sold − R&D

Data Sources & References

GSK Official Website www.gsk.com
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk